Guidelines
Latest Guidelines News
Keep up to date with all the latest news about ESMO guidelines: find out about new and updated Clinical Practice Guidelines, consensus conference-derived recommendations and eUpdates (including diagnostic and treatment algorithms and ESMO-MCBS grading), along with new and updates Guidelines Slide Sets and updates to the pocket guidelines and the mobile App - providing quick-reference material with key information.
ESMO Guidelines Methodology
To assist those using and/or evaluating the ESMO Guidelines, download the methodology here
Pocket Guidelines & Mobile App
Download the new version of our App with the latest Pocket Guidelines for oncology professionals
ESMO-MCBS
The scale uses a rational, structured and consistent approach to derive a relative ranking of the magnitude of clinically meaningful benefit that can be expected from anti-cancer treatments.
ESMO Guidelines: Real World Cases - Webinars recordings
This series brings together all the relevant stakeholders who are developing each guideline, as well as those who are consulting and implementing them.
Guidelines by Topic
The ESMO Clinical Practice Guidelines, prepared and reviewed by leading experts and based on the findings of evidence-based medicine, provide you with a set of recommendations to help patients with the best care options.
Cancer Patient Management During the COVID-19 Pandemic
These recommendations aim to develop guidance to mitigate the negative effects of the COVID-19 pandemic on the diagnosis and treatment of cancer patients
Breast Cancer
Comprehensive guidelines for early and advanced BC management plus prevention and screening for BRCA mutation carriers
Cancers of Unknown Primary Site
Definition, incidence and biology, staging and treatment of this heterogeneous group of metastatic tumours
Endocrine and Neuroendocrine Cancers
Including guidelines on thyroid and adrenal cancers, along with gastroenteropancreatic and bronchial and thymic NETs
Genitourinary Cancers
Topics include prostate, urothelial bladder, testicular, penile and renal cell cancers
Gastrointestinal Cancers
Covering the breadth of GI cancers, including biliary, gastric, oesophageal, pancreatic, anal, rectal, hepatocellular and CRC
Gynaecological Cancers
Comprehensive guidance on cervical, endometrial and ovarian cancers. Also including gestational trophoblastic disease guidelines
Haematological Malignancies
Providing guidelines on more than 15 topics in lymphoma, leukaemia and myeloma
Head and Neck Cancers
Nasopharyngeal cancer and HNSCC guidelines are included covering diagnosis through to follow-up.
Hereditary Syndromes
Prevention and screening in BRCA mutation and other breast/ovarian cancer syndromes, along with diagnosis and treatment of hereditary GI cancers
Lung and Chest Tumours
Comprehensive guidelines on early, locally advanced and metastatic NSCLC, SCLC, malignant pleural mesothelioma and thymic epithelial tumours
Melanoma
Incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up of cutaneous melanoma
Neuro-Oncology
High-grade glioma and leptomeningeal metastasis guidelines are currently provided
Sarcoma and GIST
Guidelines on soft tissues and visceral sarcomas, bone sarcomas and GIST developed in collaboration with the European Reference Networks
Supportive and Palliative Care
Supportive and palliative care are areas of high importance in oncology and ESMO published Clinical Practice Guidelines on the management of a variety of issues